Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Dec;80(3):313-32.
doi: 10.1007/s11060-006-9193-2. Epub 2006 Jun 29.

Medical management of patients with brain tumors

Affiliations
Review

Medical management of patients with brain tumors

Patrick Y Wen et al. J Neurooncol. 2006 Dec.

Abstract

The most common medical problems in brain tumor patients include the management of seizures, peritumoral edema, medication side effects, venous thromboembolism (VTE), fatigue and cognitive dysfunction. Despite their importance, there are relatively few studies specifically addressing these issues. There is increasing evidence that brain tumor patients who have not had a seizure do not benefit from prophylactic antiepileptic medications. Patients on corticosteroids are at greater risk of Pneumocystis jerovecii pneumonia and may benefit from prophylactic therapy. There is also growing evidence suggesting that anticoagulation may be more effective than inferior vena cava IVC) filtration devices for treating VTE in brain tumor patients and the risk of hemorrhage with anticoagulation is relatively small. Low-molecular weight heparin may be more effective than coumadin. Medications such as modafinil and methylphenidate have assumed an increasing role in the treatment of fatigue, while donepezil and memantine may be helpful with memory loss.

PubMed Disclaimer

Similar articles

Cited by

  • Intracranial hemorrhage in setting of glioblastoma with venous thromboembolism.
    Khoury MN, Missios S, Edwin N, Sakruti S, Barnett G, Stevens G, Peereboom DM, Khorana AA, Ahluwalia MS. Khoury MN, et al. Neurooncol Pract. 2016 Jun;3(2):87-96. doi: 10.1093/nop/npv028. Epub 2015 Aug 25. Neurooncol Pract. 2016. PMID: 31386010 Free PMC article. Review.
  • Malignant Glioma.
    Wang LM, Englander ZK, Miller ML, Bruce JN. Wang LM, et al. Adv Exp Med Biol. 2023;1405:1-30. doi: 10.1007/978-3-031-23705-8_1. Adv Exp Med Biol. 2023. PMID: 37452933 Review.
  • Polymeric Nanoparticles for the Treatment of Malignant Gliomas.
    Mahmoud BS, AlAmri AH, McConville C. Mahmoud BS, et al. Cancers (Basel). 2020 Jan 10;12(1):175. doi: 10.3390/cancers12010175. Cancers (Basel). 2020. PMID: 31936740 Free PMC article. Review.
  • Venous thromboembolism in malignant gliomas.
    Jenkins EO, Schiff D, Mackman N, Key NS. Jenkins EO, et al. J Thromb Haemost. 2010 Feb;8(2):221-7. doi: 10.1111/j.1538-7836.2009.03690.x. Epub 2009 Nov 13. J Thromb Haemost. 2010. PMID: 19912518 Free PMC article. Review.
  • Palliative Care in Neuro-oncology: an Update.
    Rhee JY, Strander S, Podgurski A, Chiu D, Brizzi K, Forst DA. Rhee JY, et al. Curr Neurol Neurosci Rep. 2023 Nov;23(11):645-656. doi: 10.1007/s11910-023-01301-2. Epub 2023 Sep 26. Curr Neurol Neurosci Rep. 2023. PMID: 37751050 Review.

References

    1. J Pain Symptom Manage. 1998 Sep;16(3):193-8 - PubMed
    1. J Neurooncol. 2003 Jul;63(3):263-70 - PubMed
    1. Neurology. 2005 Jun 28;64(12 Suppl 3):S2-11 - PubMed
    1. J Clin Oncol. 2005 Apr 1;23(10):2123-9 - PubMed
    1. Cancer Res. 1996 Mar 15;56(6):1352-60 - PubMed

Publication types

MeSH terms